#USA #Houston #financial results #Nutex Health #NASDAQ NUTX

Nutex Health Reflects on a Stellar 2024 Financial Year

Nutex Health Inc., headquartered in Houston, Texas, has reported record-breaking financial results for both the fourth quarter and the entire fiscal year of 2024. With a robust revenue growth of 93.8%, the company achieved a total revenue of $479.9 million, compared to $247.6 million in 2023. This remarkable increase has been attributed to various factors, especially the success of their arbitration efforts that contributed approximately $169.7 million in additional revenue.

Among the significant highlights for the fiscal year ending December 31, 2024, is a net income of $52.2 million, a sharp turnaround from the net loss of $45.8 million in the previous year. This exceptional jump underscores the operational strength of Nutex Health, particularly in optimizing efficiency through their integrated healthcare delivery model composed of microhospitals and outpatient departments across 11 states.

Furthermore, the diluted Earnings Per Share (EPS) surged to $9.71, contrasting drastically with a loss of $10.39 a year prior. Such significant improvement demonstrates the effectiveness of Nutex Health’s strategies and patient-focused services. Notably, while the company reported an EBITDA of $98.4 million, they also reached an adjusted EBITDA of $123.7 million, which marked a striking 1,045.4% increase from the previous year.

Fourth Quarter Results

The fourth quarter alone showcased a total revenue of $257.6 million, representing an astonishing growth of 269.6% from $69.7 million in Q4 of 2023. Similar to previous quarters, the arbitration process was a significant contributor, accounting for about 90.3% of the overall revenue increase during this period.

Operating income also experienced remarkable growth, transitioning from a loss of approximately $26.1 million in Q4 of 2023 to a profit of $114.2 million in Q4 of 2024. The quarterly net income attributable to Nutex Health was reported at $61.7 million, versus a loss of $31.7 million a year earlier.

As part of their commitment to service enhancement, total visits across Nutex Health’s facilities reached 168,388 for the fiscal year, a 16.9% increase compared to the year before. This growth reflects the growing trust and demand for Nutex's care models, which place emphasis on both efficiency and quality of care.

Looking Ahead

Nutex Health’s executives expressed optimism about future growth. CFO Jon Bates noted the company's strong cash flow and operational efficiency, while COO Josh DeTillio highlighted significant operational improvements across all metrics. Tom Vo, Chairman and CEO, reflected on the progress and momentum heading into 2025, underscoring the team's dedication to patient care.

The successes in 2024 not only illustrate a triumph over previous challenges but also set a clear trajectory for Nutex Health’s strategic planning and operational goals as they endeavor to expand their innovative healthcare solutions further.

As they continue to optimize operations and explore growth opportunities amidst changing healthcare dynamics, Nutex Health remains focused on delivering quality healthcare solutions across its microhospital network and has positioned itself as a leader in integrated health delivery systems.

For more detailed financial results, stakeholders are encouraged to review the company’s Annual Report on Form 10-K, available on the SEC’s website.